Articles published by Bicycle Therapeutics
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
December 14, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers
BCYC
Bicycle Therapeutics to Host R&D Day on December 14
November 30, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers
BCYC
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
September 11, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers
BCYC
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 05, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers
BCYC
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
February 28, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers
BCYC
Bicycle Therapeutics Announces Phase I Dose Escalation Results from Ongoing Phase I/II Study of BT8009
February 14, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers
BCYC
Bicycle Therapeutics Announces First Patient Dosed in BT8009 Phase II Expansion Cohorts and Provides Program Update
November 08, 2022
From Bicycle Therapeutics
Via Business Wire
Tickers
BCYC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free